AAAAAA

   
Results: 1-18 |
Results: 18
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Busto, R Armatis, P Halmos, G
Citation: I. Chatzistamou et al., Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone, ANTI-CANC D, 12(9), 2001, pp. 761-768
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide
Authors: Rekasi, Z Schally, AV Plonowski, A Czompoly, T Csernus, B Varga, JL
Citation: Z. Rekasi et al., Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide, PROSTATE, 48(3), 2001, pp. 188-199
Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways
Authors: Rekasi, Z Varga, JL Schally, AV Plonowski, A Halmos, G Csernus, B Armatis, P Groot, K
Citation: Z. Rekasi et al., Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways, PEPTIDES, 22(6), 2001, pp. 879-886
Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Armatis, P Bajo, AM
Citation: I. Chatzistamou et al., Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide, J CANC RES, 127(11), 2001, pp. 645-652
Hypothalamic hormones and cancer
Authors: Schally, AV Comaru-Schally, AM Nagy, A Kovacs, M Szepeshazi, K Plonowski, A Varga, JL Halmos, G
Citation: Av. Schally et al., Hypothalamic hormones and cancer, FRONT NEURO, 22(4), 2001, pp. 248-291
Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice
Authors: Chatzistamou, I Schally, AV Varga, JL Groot, K Armatis, P Busto, R Halmos, G
Citation: I. Chatzistamou et al., Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cellline xenografted into nude mice, J CLIN END, 86(5), 2001, pp. 2144-2152
Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth
Authors: Szepeshazi, K Schally, AV Armatis, P Groot, K Hebert, F Feil, A Varga, JL Halmos, G
Citation: K. Szepeshazi et al., Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth, ENDOCRINOL, 142(10), 2001, pp. 4371-4378
Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice
Authors: Kiaris, H Schally, AV Varga, JL
Citation: H. Kiaris et al., Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice, NEOPLASIA, 2(3), 2000, pp. 242-250
Suppression of tumor growth by growth hormone-releasing hormone antagonistJV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma
Authors: Kiaris, H Schally, AV Varga, JL
Citation: H. Kiaris et al., Suppression of tumor growth by growth hormone-releasing hormone antagonistJV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma, CANCER LETT, 161(2), 2000, pp. 149-155
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
Authors: Plonowski, A Schally, AV Varga, JL Rekasi, Z Hebert, F Halmos, G Groot, K
Citation: A. Plonowski et al., Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways, PROSTATE, 44(2), 2000, pp. 172-180
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
Authors: Kahan, Z Varga, JL Schally, AV Rekasi, Z Armatis, P Chatzistamou, I Czompoly, T Halmos, G
Citation: Z. Kahan et al., Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice, BREAST CANC, 60(1), 2000, pp. 71-79
Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro
Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro, P NAS US, 97(3), 2000, pp. 1218-1223
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
Authors: Halmos, G Schally, AV Varga, JL Plonowski, A Rekasi, Z Czompoly, T
Citation: G. Halmos et al., Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone, P NAS US, 97(19), 2000, pp. 10555-10560
Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancer
Authors: Rekasi, Z Varga, JL Schally, AV Halmos, G Armatis, P Groot, K Czompoly, T
Citation: Z. Rekasi et al., Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: Evidence from in vitro studies on human prostatic and pancreatic cancer, ENDOCRINOL, 141(6), 2000, pp. 2120-2128
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
Authors: Szepeshazi, K Schally, AV Groot, K Armatis, P Halmos, G Hebert, F Szende, B Varga, JL Zarandi, M
Citation: K. Szepeshazi et al., Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers, BR J CANC, 82(10), 2000, pp. 1724-1731
Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents
Authors: Schally, AV Varga, JL
Citation: Av. Schally et Jl. Varga, Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents, TRENDS ENDO, 10(10), 1999, pp. 383-391
Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma
Authors: Kiaris, H Schally, AV Varga, JL Groot, K Armatis, P
Citation: H. Kiaris et al., Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma, P NAS US, 96(26), 1999, pp. 14894-14898
Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities
Authors: Varga, JL Schally, AV Csernus, VJ Zarandi, M Halmos, G Groot, K Rekasi, Z
Citation: Jl. Varga et al., Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities, P NAS US, 96(2), 1999, pp. 692-697
Risultati: 1-18 |